Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain

Journal of Cerebral Blood Flow and Metabolism

Volumn 19, Issue 10, 1999, Pages 1164-1173

  Olsson, Hans ^a,b   Halldin, Christer ^a   Swahn, Carl Gunnar ^a   Farde, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Compartment analysis; D2 dopamine receptors; Extrastriatal; Human; Positron emission tomography; 11C FLB 457

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; CARBON; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; ISOREMOXIPRIDE; PYRROLIDINE DERIVATIVE; SALICYLAMIDE DERIVATIVE;

ADULT; ARTICLE; BINDING AFFINITY; CORPUS STRIATUM; HUMAN; HUMAN EXPERIMENT; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RECEPTOR BINDING; SCHIZOPHRENIA; BINDING SITE; CEREBELLUM; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; KINETICS; METABOLISM; METHODOLOGY; PUTAMEN; STANDARD; TEMPORAL LOBE; THALAMUS;

ADULT; BINDING SITES; CARBON RADIOISOTOPES; CEREBELLUM; DOPAMINE ANTAGONISTS; HUMANS; KINETICS; MALE; PUTAMEN; PYRROLIDINES; RECEPTORS, DOPAMINE D2; REFERENCE STANDARDS; SALICYLAMIDES; TEMPORAL LOBE; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033249438     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199910000-00013     Document Type: Article

References (17)

1. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19:716-723
2. Andén N, Stock G (1973) Effect of clozapine on the turnover of dopamine in the corpus striatum and the limbic system. J Pharmacol 25:346
3. Bergström M, Boëthius J, Eriksson L, Greitz T, Ribbe T, Widén L (1981) Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comp Assist Tomogr 5:136-141
4. 2 receptor mRNA. Brain Res 564:203-219
5. Bunney B (1984) Antipsychotic drug effects on the electrical activity of dopaminergic neurons. TINS (7):212-215
6. Costall B, Naylor R (1976) Antagonism of the hyperactivity induced by dopamine applied intracerebrally to nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. Eur J Pharmacol 35:161-168
7. Davis K, Kahn R, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474-1486
8. Deutch AY, Duman RS (1996) The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience 70:377-389
9. Eriksson L, Holte S, Bohm C, Kesselberg M, Hovander B (1988) Automated blood sampling systems for positron emission tomography. IEEE Trans Nucl Sci 35:703-707
10. Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström C-G, Litton J-E, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82:3863-3867
11. 2-dopamine receptors studied by PET - a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9:696-708
12. 2-dopamine receptors and personality traits. Nature 385:590
13. 11C]raclopride in man. Synapse 20:200-208
14. 2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology 133:396-404
15. Fibiger HC (1994) Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry. J Clin Psychiatry 55:33-36
16. Gurevich EV, Joyce JN (1999) Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacol 20:60-80
17. 125I]epidepride. Synapse 23:115-123